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Macrolides long-term therapy has demonstrated beneﬁcial effects on pulmonary
status in CF patients, but there is a lack of literature on microbiological variations
possibly associated with it. We studied lung function (FEV1%), nutritional status
(BMI) and sputum culture in 65 CF patients (32 males, mean age 29.11 years), in
whom long-term Azithromycin therapy (250–500mg/die, 3/7 days a week, for at
least 1 year) was performed. Moreover we compared, for sputum cultures results, 10
patients (Group A: 4 males, mean age 23.5 years, range 12.5−44, Sputum culture:
S.a.oxa S in 7/10, S.a. oxa R in 1/10, S.a.+ P.a. in 2/10) out of these series, with 10
CF patients (Group B) matched for age and sputum culture, in whom long-term
Azithromycin therapy was never performed.
In 44/65 patients (68%) mean BMI improved (T0: 19.64; T12: 19.83); in 41/64
patients (63%) mean FEV1% increased (T0: 56.17%; T12: 60.21%); in 20/65
patients sputum bacteria showed new multiresistance antibiotic pattern and in 14/65
(21.5%) sputum cultures exhibited small colony variant (SCV) as new bacterial
phenotypes: S.a. in 9 pts, P.a. in 6 pts and mucoid P.a. in 1 pt.
The sputum culture comparison between Group A and Group B showed no differ-
ence on new multiresistence antibiotic bacteria developement, but 2 SCV S.a. and
1 SCV P.a. in Group A and no SCV bacteria in Group B were isolated.
In conclusion our data, according to international leterature, demonstrate that
long-term Macrolides therapy have a positive impact on respiratory function and
nutritional status in CF, but we hypothesize that this therapy could be associated
with SCV bacteria development in CF sputa.
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Background: Chronic lung infection with P. aeruginosa is the dominating cause of
death in patients with CF. The chronic lung infection often lasts for decades with
just one clone. As a result of inﬂammation, antibiotic treatment and different niches
in the lungs the clone undergoes genetic changes resulting in diversifying geno-
and phenotypes. Such adaptation may generate different host responses. However,
experimental animal infections with P. aeruginosa are limited to 2 weeks.
Experiments: To experimentally reﬂect the year-long lung infection in CF, groups
of BALB/c mice were infected with mucoid or non-mucoid isotypic clones isolated
during different periods (1980, 1988, 1997, 1999 and 2003) of the lung infection
of one CF patient, using the seaweed alginate model.
Results: The non-mucoid clones reduced their virulence over time, resulting in
faster clearing of the bacteria from the lungs (p< 0.035), improved histopathology
(p< 0.05) and reduced pulmonary MIP-2 and G-CSF (p< 0.005). In contrast,
the mucoid clones were more virulent. Moreover, their virulence increased with
time resulting in impairment of clearing of the latest clone (p< 0.0001), severe
inﬂammation in peripheral airways (p< 0.05) and increased pulmonary MIP-2 and
G-CSF production (p< 0.04). Similar results were obtained using comparable sets
of isotypic clones from four additional CF patients.
Conclusion: Adaptation of P. aeruginosa in CF is reﬂected by changed ability
to establish lung infection and results in distinct host responses to mucoid and
non-mucoid phenotypes. The present new infection model reﬂects important char-
acteristics of the year-long P. aeruginosa lung infection in CF.
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Background: Cystic ﬁbrosis has a typical course of exacerbations and remission
of lung disease, suggesting inﬂuence of external factors like respiratory viral
infections. We reported clinical evidence suggesting that RSV inﬂuences acquisition
and chronic infection with P. aeruginosa. We recently described that in vitro RSV
infection increases infectivity of P. aeruginosa in respiratory epithelial cells. We
studied whether RSV has an enhancing effect on acute P. aeruginosa lung infection
in a mouse model.
Methods: We used Balb/c mice and a non-mucoid, early P. aeruginosa clinical
isolate. Mice were inoculated with bacteria alone or together with RSV. Lung
function was measured at baseline and at termination of the experiment. Lungs were
harvested 24 hours after inoculation and randomly selected for either histopathology
or bacteriology.
Results: A signiﬁcantly higher number of bacteria was found in the lungs of co-
infected mice, compared to mice infected with bacteria alone (median 1.8 x 105
and 9.1 x 101 CFU/mouse respectively, p< 0.01). Lung function changes were
most outspoken in co-infected mice. Histopathology showed alveolar inﬂammation
in both groups.
Conclusion: In mice, co-infection with RSV and P. aeruginosa leads to reduced
clearance of bacteria and a trend towards more outspoken lung function changes,
compared to infection with bacteria alone. This supports clinical and in vitro
evidence for an enhancing effect of RSV on P. aeruginosa infectivity, which
is important in the understanding of the initial mechanisms of P. aeruginosa
colonization in CF patients.
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Acute and chronic sinusitis is common complications of CF. We have genotyped
P. aeruginosa (PA) lung isolates from CF children by using PFGE. After antibiotic
eradication of PA, new colonising isolates had the same genotype as the initial
colonising strain. It has been suggested that the sinuses may serve as a reservoir
for bacterial lung infections.
Twenty-ﬁve CF patients (median age: 18 yrs, range 6−50) have been treated with
FESS to evaluate whether their sinuses serve as a bacterial reservoir. Eleven were
chronically infected (7 with PA, 2 with BC, 1 with AX, 1 with Moraxella) and 14
were intermittently colonised (8 with PA and 6 with other CF pathogens) in their
lungs.
We found good agreement between lung and sinus bacteriology in 24/25 (95%) of
the patients. Seven patients chronically infected with PA had the same genotype in
their lungs for >15 years and this genotype was identical to the PA obtained from
their paranasal sinuses. Six of eight children colonised with PA had growth of the
same genotype of PA in their sinuses and sputum samples collected up to 2 years
prior to the FESS operation. In Gram stained smears from the sinuses we found that
the bacteria were organised in bioﬁlm structures similar to those seen in the lungs.
In sinus smears we detected few inﬂammatory cells compared to lung smears.
The sinus colonisation is immunological silent in intermittently colonised patients
and causes only an insigniﬁcant anti-PA antibody response (Th1 response). Because
of the weak signs of infection, the sinus colonisation can proceed unnoticed into a
permanent infectious focus that cannot be eradicated with antibiotics.
